BI Asset Management Fondsmaeglerselskab A S Decreases Stock Position in HCA Healthcare, Inc. $HCA

BI Asset Management Fondsmaeglerselskab A S reduced its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 2.9% during the third quarter, HoldingsChannel reports. The firm owned 143,627 shares of the company’s stock after selling 4,327 shares during the quarter. BI Asset Management Fondsmaeglerselskab A S’s holdings in HCA Healthcare were worth $61,214,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Norges Bank acquired a new position in shares of HCA Healthcare in the second quarter worth about $1,152,408,000. Viking Global Investors LP boosted its stake in shares of HCA Healthcare by 58.5% during the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after buying an additional 690,773 shares during the last quarter. Nordea Investment Management AB increased its stake in shares of HCA Healthcare by 5.2% in the third quarter. Nordea Investment Management AB now owns 975,741 shares of the company’s stock worth $415,656,000 after buying an additional 47,960 shares during the last quarter. Pacer Advisors Inc. grew its holdings in HCA Healthcare by 6,115.3% during the 3rd quarter. Pacer Advisors Inc. now owns 911,096 shares of the company’s stock worth $388,309,000 after acquiring an additional 896,437 shares in the last quarter. Finally, LSV Asset Management raised its stake in shares of HCA Healthcare by 0.4% in the 2nd quarter. LSV Asset Management now owns 868,849 shares of the company’s stock valued at $332,856,000 after purchasing an additional 3,396 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Trading Down 1.2%

HCA opened at $493.09 on Thursday. HCA Healthcare, Inc. has a twelve month low of $295.00 and a twelve month high of $527.55. The stock has a market cap of $112.52 billion, a PE ratio of 17.37, a price-to-earnings-growth ratio of 1.53 and a beta of 1.36. The business’s 50 day moving average is $480.20 and its 200-day moving average is $440.62.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, beating the consensus estimate of $7.37 by $0.64. The firm had revenue of $19.51 billion for the quarter, compared to the consensus estimate of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The firm’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $6.22 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be given a dividend of $0.78 per share. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date is Tuesday, March 17th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s payout ratio is presently 10.99%.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on HCA shares. KeyCorp set a $503.00 price objective on HCA Healthcare in a report on Wednesday, January 28th. Mizuho set a $540.00 price objective on HCA Healthcare in a research note on Monday. Zacks Research cut shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 27th. Sanford C. Bernstein reiterated a “market perform” rating on shares of HCA Healthcare in a research note on Wednesday, January 28th. Finally, Barclays upped their target price on HCA Healthcare from $494.00 to $551.00 and gave the company an “overweight” rating in a report on Wednesday, January 28th. Fifteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $519.71.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.